Session

IBD (Posters)

ENDOSCOPIC FEATURES OF NON-IBD COLITIS
ENDOSCOPIC FEATURES OF NON-IBD COLITIS

IBD (Posters)  et al.

METAGENOMIC ANALYSIS OF A SIGNATURE GUT MICROBIOME BIOMARKER IN CROHN'S DISEASE ACROSS FIVE POPULATIONS
METAGENOMIC ANALYSIS OF A SIGNATURE GUT MICROBIOME BIOMARKER IN CROHN'S DISEASE ACROSS FIVE POPULATIONS

IBD (Posters)  et al.

EXCLUSIVE ENTERAL NUTRITION DRIVES PROTECTIVE MICROBIOME MODULATION IN PEDIATRIC CROHN’S DISEASE
EXCLUSIVE ENTERAL NUTRITION DRIVES PROTECTIVE MICROBIOME MODULATION IN PEDIATRIC CROHN’S DISEASE

IBD (Posters)  et al.

HIDRADENITIS SUPPURATIVA AND INFLAMMATORY BOWEL DISEASE IN A CASE-CONTROL STUDY
HIDRADENITIS SUPPURATIVA AND INFLAMMATORY BOWEL DISEASE IN A CASE-CONTROL STUDY

IBD (Posters)  et al.

RELATIONSHIP BETWEEN INTESTINAL ULTRASOUND, FECAL CALPROTECTIN AND HARVEY BRADSHAW INDEX IN THE ASSESSMENT OF INFLAMMATORY ACTIVITY IN CROHN'S DISEASE
RELATIONSHIP BETWEEN INTESTINAL ULTRASOUND, FECAL CALPROTECTIN AND HARVEY BRADSHAW INDEX IN THE ASSESSMENT OF INFLAMMATORY ACTIVITY IN CROHN'S DISEASE

IBD (Posters)  et al.

USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS UP TO WEEK 104 OF THE STARDUST TRIAL
USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS UP TO WEEK 104 OF THE STARDUST TRIAL

IBD (Posters)  et al.

MUCOSAL AND PLASMA METABOLOMES IN NEW-ONSET PAEDIATRIC INFLAMMATORY BOWEL DISEASE: CORRELATIONS WITH DISEASE CHARACTERISTICS AND PLASMA INFLAMMATION PROTEIN MARKERS
MUCOSAL AND PLASMA METABOLOMES IN NEW-ONSET PAEDIATRIC INFLAMMATORY BOWEL DISEASE: CORRELATIONS WITH DISEASE CHARACTERISTICS AND PLASMA INFLAMMATION PROTEIN MARKERS

IBD (Posters)  et al.

SMOKING AND COLITIS-ASSOCIATED COLORECTAL NEOPLASIA: EXPLORING THE RELATIONSHIP
SMOKING AND COLITIS-ASSOCIATED COLORECTAL NEOPLASIA: EXPLORING THE RELATIONSHIP

IBD (Posters)  et al.

SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

IBD (Posters)  et al.

THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-COV-2 VACCINES IN PATIENTS WITH INFLAMMATORY BOWEL- AND JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPY COMPARED TO HEALTHY CONTROLS – A PROSPECTIVE COHORT STUDY
THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-COV-2 VACCINES IN PATIENTS WITH INFLAMMATORY BOWEL- AND JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPY COMPARED TO HEALTHY CONTROLS – A PROSPECTIVE COHORT STUDY

IBD (Posters)  et al.

HOW IS THE CLINICAL COURSE AND DRUG TOXICITY IN LATE-ONSET IBD PATIENTS?
HOW IS THE CLINICAL COURSE AND DRUG TOXICITY IN LATE-ONSET IBD PATIENTS?

IBD (Posters)  et al.

HEAD-TO-HEAD PHARMACOKINETIC ANALYSIS OF INFLIXIMAB MONO- VS COMBINATION THERAPY IN PAEDIATRIC CROHN’S DISEASE
HEAD-TO-HEAD PHARMACOKINETIC ANALYSIS OF INFLIXIMAB MONO- VS COMBINATION THERAPY IN PAEDIATRIC CROHN’S DISEASE

IBD (Posters)  et al.

PREDICTORS OF NON-RESPONSE TO STEROIDS IN SEVERE ACUTE ULCERATIVE COLITIS: A SINGLE-CENTRE RETROSPECTIVE STUDY
PREDICTORS OF NON-RESPONSE TO STEROIDS IN SEVERE ACUTE ULCERATIVE COLITIS: A SINGLE-CENTRE RETROSPECTIVE STUDY

IBD (Posters)  et al.

RADIOMICS COULD PREDICT SURGERY AT 10 YEARS IN CROHN’S DISEASE
RADIOMICS COULD PREDICT SURGERY AT 10 YEARS IN CROHN’S DISEASE

IBD (Posters)  et al.

SARCOPENIA IS A POOR PROGNOSTIC FACTOR FOR ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN’S DISEASE
SARCOPENIA IS A POOR PROGNOSTIC FACTOR FOR ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN’S DISEASE

IBD (Posters)  et al.

IMPACT OF CONCOMITANT THIOPURINE ON THE EFFICACY AND SAFETY OF FILGOTINIB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY
IMPACT OF CONCOMITANT THIOPURINE ON THE EFFICACY AND SAFETY OF FILGOTINIB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

IBD (Posters)  et al.

HAS BODY IMAGE IMPROVED AMONGST INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE IN THE MODERN ERA?
HAS BODY IMAGE IMPROVED AMONGST INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE IN THE MODERN ERA?

IBD (Posters)  et al.

HISTOLOGICAL FEATURES OF JOINT INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PERIPHERAL ARTHRITIS
HISTOLOGICAL FEATURES OF JOINT INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PERIPHERAL ARTHRITIS

IBD (Posters)  et al.

A SYSTEMATIC REVIEW AND META-ANALYSIS OF SLEEP QUALITY IN INACTIVE INFLAMMATORY BOWEL DISEASE
A SYSTEMATIC REVIEW AND META-ANALYSIS OF SLEEP QUALITY IN INACTIVE INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

ENDOSCOPIC AND HISTOLOGICAL PREDICTORS OF COMPLETE REMISSION AFTER THREE MONTHS OF CONVENTIONAL TREATMENT IN ULCERATIVE COLITIS BASED ON MAYO ENDOSCOPIC SCORE AND NANCY HISTOLOGICAL INDEX
ENDOSCOPIC AND HISTOLOGICAL PREDICTORS OF COMPLETE REMISSION AFTER THREE MONTHS OF CONVENTIONAL TREATMENT IN ULCERATIVE COLITIS BASED ON MAYO ENDOSCOPIC SCORE AND NANCY HISTOLOGICAL INDEX

IBD (Posters)  et al.

Item 401 - 420 / 612
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
21
22 23 24 25 26 27 28 29 30 31